Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
종목 코드 AORT
회사 이름Artivion Inc
상장일Feb 12, 1993
CEOMackin (James Patrick)
직원 수1600
유형Ordinary Share
회계 연도 종료Feb 12
주소1655 Roberts Boulevard N W
도시KENNESAW
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호30144
전화17704193355
웹사이트https://artivion.com/
종목 코드 AORT
상장일Feb 12, 1993
CEOMackin (James Patrick)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음